Is this U.S.-China selloff a buy? A top Wall Street voice weighs in
Investing.com - Jefferies has downgraded Diagnostyka SA (WAR:DIA) from Buy to Hold while raising its price target to PLN204.00 from PLN190.00.
The Polish diagnostic services company has seen its shares nearly double since its initial public offering in January, prompting Jefferies to suggest the stock is due for a pause despite strong performance.
Jefferies raised its 2025 EBITDA estimate for Diagnostyka by approximately 2%, but noted limited near-term margin expansion opportunities for the company.
The research firm indicated that inflation pricing has been driving the majority of top-line upgrades for Diagnostyka, rather than operational improvements or market share gains.
The new price target of PLN204.00 represents minimal upside at 10.9 times 2026 EV/EBITDA, with Jefferies stating it sees "better value elsewhere" in the sector.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.